What's Going On With Altimmune (ALT) Stock Today?
Altimmune to Present at Upcoming EASL International Liver Congress 2025
Altimmune to Participate in the Citizens Life Sciences Conference
Will Pfizer Will Acquire Altimmune or Viking Therapeutics After Its Obesity Pill Setback?
Evercore Maintains Altimmune(ALT.US) With Buy Rating, Maintains Target Price $25
Analysts Are Bullish on These Healthcare Stocks: Summit Therapeutics (SMMT), Altimmune (ALT)
$ALT Stock Is up 2% Today. Here's What We See in Our Data.
SA Asks: What's the Best Weight-loss Drug Stock Right Now?
Viking, Structure, Metsera on a Tear as Pfizer Drops Obesity Pill
What's Going On With Viking Therapeutics, Structure Therapeutics Stock On Monday?
Altimmune's US$42m Market Cap Fall Books Insider Losses
Altimmune Management to Meet With Piper Sandler
8 Analysts Assess Altimmune: What You Need To Know
Analysts Offer Insights on Healthcare Companies: Altimmune (ALT), Cue Biopharma (CUE) and Atricure (ATRC)
Altimmune's Strategic Positioning and Promising Future in Obesity and MASH Treatment Markets
H.C. Wainwright Maintains Altimmune(ALT.US) With Buy Rating, Maintains Target Price $12
Express News | HC Wainwright & Co. Reiterates Buy on Altimmune, Maintains $12 Price Target
Altimmune's Pemvidutide: A Promising Best-in-Class Therapy With Broad Potential and Strong Buy Rating
The tariff war between the US and Europe is escalating, and Trump's 'tariff big stick' is making the pharmaceutical industry tremble.
Pharmaceutical companies are urging the Trump administration and EU officials to exclude Medical products from the escalation of the trade war.
Key Deals This Week: ServiceNow, Eaton, Crown Castle, Victoria's Secret and More